Here we go again!
ap-travel / Alamy Stock Photo
These results can help allay previous concerns in Europe about a lack of trial data for older people.
The AstraZeneca vaccine is already in use in many places.
AP Photo/Christophe Ena
AstraZeneca just announced results from its US-based trial. It found the vaccine to be 79% effective and safe for use, despite recent concerns around reports of blood clots.
Dave Hunt/AAP
From today, around 1,000 clinics around the country can begin vaccinating eligible Australians.
fabrus/Alamy Stock Photo
Underlying medicines ‘do no harm’ principle is a deeper claim that it is worse to do harm than to allow harm to happen.
Roland Magnusson/Shutterstock
Supply chain issues can be addressed – but the issues with the AstraZeneca vaccine are political, too.
The AstraZeneca vaccine has been investigated and found safe, but will countries be able to get enough of it?
Marc Bruxelle/Alamy Stock Photo
The European Medicines Agency has said the Oxford/AstraZeneca vaccine is not associated with an increased overall risk of developing blood clots.
Oded Balilty/AP
It’s not too late for Australia to repair our vaccine strategy, though we will never make up for the months lost.
Mick Tsikas/AAP
The government is gifting 8,000 doses of COVID-19 vaccines to Papua New Guinea for frontline health workers, and is requesting an additional 1,000,000 doses from European authorities for the pacific nation.
Wojciech Stróżyk/Alamy Stock Photo
Suspensions of the AstraZeneca vaccine may dent confidence and will slow down coverage – arguably creating a greater risk to public health.
Blood clots can form in the lungs, brain, heart, or veins.
SciePro/Shutterstock
Blood clots form to prevent blood loss both inside and outside the body. But they can become dangerous if they get dislodged from where they form.
Alessandro Di Marco/EPA-EFE
Injected vaccines tend to generate good immunity overall but less of a response in the nose and throat, where the virus enters and spreads from.
Remko de Waal/EPA/AAP
Data from clinical trials and the real world COVID vaccine rollout suggest blood clots occur no more frequently in vaccinated people than they do in the general population.
Andrea Fasani/EPA-EFE
The European Medicines Agency has found no link between thrombosis and the AstraZeneca vaccine, but precautionary investigations are continuing in some countries.
A COVID-19 vaccine is administered at a clinic at Olympic Stadium in Montréal on March 1, 2021, marking the beginning of mass vaccination in the Province of Québec based on age.
THE CANADIAN PRESS/Paul Chiasson
With four COVID-19 vaccines approved for use in Canada, it’s time to answer FAQs about efficacy, immunity, eradication and variants.
Cecilia Fabiano/AP
Italy’s decision to block export of AstraZeneca vaccines to Australia will likely not impact our vaccine roll-out. But vaccine scarcity is a looming problem in other parts of the world.
By early March only one-third of Germany’s stocks of the Oxford/AstraZeneca vaccine had been used – possibly because of misinformation about its effects.
Sean Gallup/EPA-EFE
Fears that the vaccine doesn’t work in older people appear unfounded.
A woman waiting for a COVID-19 vaccine in Salisbury cathedral, one of more than a thousand vaccination sites set up in the UK.
Neil Hall/EPA-EFE
Good decisions and investment have built a strong supply chain, while various experts have helped with distribution.
Russian Sputnik V vaccines arriving at Silvio Pettiross airport in Ciudad Luque, Paraguay, February 2021.
EPA-EFE/Nathalia Aguilar
The global vaccine rollout has not been free from geopolitical rivalries and point-scoring.
Olivier Chassignole/AP
The Oxford/AstraZeneca vaccine is the second COVID shot to be approved in Australia, and it’s likely Australians will start receiving it next month.
Liselotte Sabroe/EPA/AAP
Australia should pivot to a high-efficacy vaccine like Pfizer or Novavax to give us the best chance of achieving herd immunity.